News

News Archive

Experts Call for Closer Collaboration in Translational Medicine Experts Call for Closer Collaboration in Translational Medicine

Wednesday 27th May 2015 marked the first day of the EATRIS Building Bridges in Translational Medicine conference where leading experts called for closer industry-academia collaboration.

Pistoia Alliance Launches New Map of Alliances project Pistoia Alliance Launches New Map of Alliances project

Map of Alliances will catalogue the complex world of life science collaborations

Modern Alchemy: TSRI Chemists Devise Synthesis of Valuable Exotic Compounds Modern Alchemy: TSRI Chemists Devise Synthesis of Valuable Exotic Compounds

Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesizing “amines,” a class of organic compounds prominent in drugs and other modern products.

BioTrinity Confirming Its Position as the Leading Investment and Biopartnering Conference in Europe BioTrinity Confirming Its Position as the Leading Investment and Biopartnering Conference in Europe

BioTrinity 2015 hosted nearly 950 executives and investors from the life science sector

New cloud based assessment tool to accelerate development of Alzheimer’s treatments New cloud based assessment tool to accelerate development of Alzheimer’s treatments

Reliable cognitive measures for patients with Alzheimer's disease are essential when testing potential new drug interventions. The high attrition rate in Alzheimer’s disease clinical trials highlights the need for more sensitive analytical tools to be used throughout the drug development process. Global science and technology company Cambridge Cognition has made a significant advancement towards this goal; today announcing a powerful new cognitive assessment product that brings efficacy testing of Alzheimer’s treatments into the digital age.

The Current issue of “The view from here” discusses Biotherapeutics The Current issue of “The view from here” discusses Biotherapeutics

The topic of this month’s newsletter from Drug Discovery Today is Biotherapeutics

TSRI Scientists Find Hyped New Recreational Drug 'Flakka' Is As Addictive As 'Bath Salts' TSRI Scientists Find Hyped New Recreational Drug 'Flakka' Is As Addictive As 'Bath Salts'

Scientists at The Scripps Research Institute (TSRI) have found using animal models that the new recreational drug alpha-PVP (“flakka”) seems equivalently potent as a stimulant, and therefore as addictive, as its chemical cousin MDPV (“bath salts”).

TSRI Researchers Connect Haywire Protein to Breast Cancer, Leukemia TSRI Researchers Connect Haywire Protein to Breast Cancer, Leukemia

A new study led by scientists at The Scripps Research Institute (TSRI) sheds light on the cause of some cancers, including breast cancer and leukemia.

Draft legislation will create more opportunities to market new drugs in the UK but companies will need to tread carefully, says Withers & Rogers Draft legislation will create more opportunities to market new drugs in the UK but companies will need to tread carefully, says Withers & Rogers

A bill which could make it easier to secure licences for off-patent drugs will open up market opportunities but companies will need to tread carefully, according to intellectual property firm Withers & Rogers.

Study Finds Metabolic Link Between Bacterial ‘Biofilms’ and Colon Cancer Study Finds Metabolic Link Between Bacterial ‘Biofilms’ and Colon Cancer

A team led by scientists at The Scripps Research Institute (TSRI) and Johns Hopkins University School of Medicine has uncovered a big clue to how bacteria may promote some colon cancers.

Professor Alan Boyd Elected President of the Faculty of Pharmaceutical Medicine Professor Alan Boyd Elected President of the Faculty of Pharmaceutical Medicine

Professor Alan Boyd, owner of Boyd's consultancy business, has been elected as President of the Faculty of Pharmaceutical Medicine. Professor Boyd, who is currently Vice President of the Faculty, will take up office on 19th November 2015.